HuGE Literature Finder
Records
1
-
5
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome. Journal of gastroenterology and hepatology 2014 Jun 29 (6): 1186-91. Jiang Yingjie, Nie Yuqiang, Li Yuyuan, Zhang Lo |
Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. American journal of physiology. Gastrointestinal and liver physiology 2013 Jan . Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR |
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2012 Jan . Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR |
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology 2011 Nov 141 (5): 1638-47.e1-7. Wong Banny S, Camilleri Michael, Busciglio Irene, Carlson Paula, Szarka Lawrence A, Burton Duane, Zinsmeister Alan |
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. Journal of clinical gastroenterology 2011 Jan 45 (1): 45-9. Park Jae Myung, Choi Myung-Gyu, Cho Yu Kyung, Lee In Seok, Kim Sang Woo, Choi Kyu Yong, Chung In-S |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: